The Latest Headlines at American Banking and Market News
Rare Element Resources (OTCMKTS:REEMF) Stock Price Passes Above 50-Day Moving Average of $0.19
Rare Element Resources Ltd. (OTCMKTS:REEMF – Get Free Report)’s share price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.19 and traded as high as $0.24.... More of this article »
Directa Plus (LON:DCTA) Share Price Passes Above 50-Day Moving Average of $18.90
Directa Plus Plc (LON:DCTA – Get Free Report)’s share price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 18.90 ($0.24) and traded as high as GBX 20 ($0.25).... More of this article »
Strategic Environmental & Energy Resources (OTCMKTS:SENR) Stock Crosses Above 50-Day Moving Average of $0.08
Strategic Environmental & Energy Resources, Inc. (OTCMKTS:SENR – Get Free Report)’s share price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.08... More of this article »
Boyd Group Services (TSE:BYD) Upgraded at National Bank Financial
Boyd Group Services (TSE:BYD – Get Free Report) was upgraded by equities researchers at National Bank Financial from a “hold” rating to a “strong-buy” rating in a research report issued to clients and... More of this article »
PAVmed (NASDAQ:PAVM) Raised to Strong-Buy at Lake Street Capital
PAVmed (NASDAQ:PAVM – Get Free Report) was upgraded by stock analysts at Lake Street Capital to a “strong-buy” rating in a research report issued on Wednesday, Zacks.com reports. PAVmed Stock Performance NASDAQ PAVM... More of this article »
Zacks Small Cap Weighs in on Lobo EV Technologies Ltd.’s Q1 2024 Earnings (NASDAQ:LOBO)
Lobo EV Technologies Ltd. (NASDAQ:LOBO – Free Report) – Investment analysts at Zacks Small Cap issued their Q1 2024 earnings per share (EPS) estimates for shares of Lobo EV Technologies in a note issued to investors... More of this article »
Boot Barn (NYSE:BOOT) PT Raised to $100.00
Boot Barn (NYSE:BOOT – Get Free Report) had its price target upped by stock analysts at Robert W. Baird from $90.00 to $100.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a “neutral”... More of this article »
FY2028 EPS Estimates for Aprea Therapeutics, Inc. Reduced by Wedbush (NASDAQ:APRE)
Aprea Therapeutics, Inc. (NASDAQ:APRE – Free Report) – Investment analysts at Wedbush lowered their FY2028 earnings estimates for Aprea Therapeutics in a research note issued on Tuesday, May 14th. Wedbush analyst R.... More of this article »
Unity Biotechnology, Inc. (NASDAQ:UBX) to Post Q2 2024 Earnings of ($0.44) Per Share, HC Wainwright Forecasts
Unity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – Stock analysts at HC Wainwright raised their Q2 2024 EPS estimates for shares of Unity Biotechnology in a research report issued on Wednesday, May 15th. HC Wainwright... More of this article »
Daiwa America Lowers Dada Nexus (NASDAQ:DADA) to Moderate Buy
Dada Nexus (NASDAQ:DADA – Get Free Report) was downgraded by analysts at Daiwa America from a “strong-buy” rating to a “moderate buy” rating in a research note issued on Thursday, Zacks.com reports. Several... More of this article »
Brokers Issue Forecasts for Watsco, Inc.’s Q2 2024 Earnings (NYSE:WSO)
Watsco, Inc. (NYSE:WSO – Free Report) – Stock analysts at Zacks Research decreased their Q2 2024 earnings estimates for Watsco in a research report issued to clients and investors on Wednesday, May 15th. Zacks Research... More of this article »
Equities Analysts Set Expectations for Xcel Energy Inc.’s Q2 2024 Earnings (NASDAQ:XEL)
Xcel Energy Inc. (NASDAQ:XEL – Free Report) – Equities researchers at Zacks Research lifted their Q2 2024 earnings per share estimates for shares of Xcel Energy in a report issued on Thursday, May 16th. Zacks Research... More of this article »
Research Analysts Issue Forecasts for Unicycive Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:UNCY)
Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Free Report) – Analysts at HC Wainwright cut their Q2 2024 earnings estimates for shares of Unicycive Therapeutics in a research report issued on Tuesday, May 14th. HC Wainwright... More of this article »